Home / Everolimus / United States
US ATC L01EG02 · updated 2 Nov 2026
Everolimus shortage in United States
Is there an Everolimus shortage in United States?
Yes. As of 2 Nov 2026, 15 Everolimus products are reported short in United States, the first since 3 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Spain, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Everolimus, Tablet, 2 mg (NDC 0378-0005-85) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 3 Nov 2025 | not given | Not stated |
| US | Everolimus, Tablet, 3 mg (NDC 0378-0006-85) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 3 Nov 2025 | not given | Not stated |
| US | Everolimus, Tablet, 5 mg (NDC 0378-0007-85) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 3 Nov 2025 | not given | Not stated |
| US | Everolimus, Tablet, 10 mg (NDC 49884-128-91) discontinuation | Endo Pharmaceuticals, Inc. | 6 Jan 2026 | not given | Not stated |
| US | Everolimus, Tablet, 2.5 mg (NDC 49884-119-91) discontinuation | Endo Pharmaceuticals, Inc. | 6 Jan 2026 | not given | Not stated |
| US | Everolimus, Tablet, 5 mg (NDC 49884-125-91) discontinuation | Endo Pharmaceuticals, Inc. | 6 Jan 2026 | not given | Not stated |
| US | Everolimus, Tablet, 7.5 mg (NDC 49884-127-91) discontinuation | Endo Pharmaceuticals, Inc. | 6 Jan 2026 | not given | Not stated |
| US | Everolimus, Tablet, 10 mg (NDC 0093-7769-24) discontinuation | Teva Pharmaceuticals USA, Inc. | 2 Mar 2026 | not given | Not stated |
| US | Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24) discontinuation | Teva Pharmaceuticals USA, Inc. | 2 Mar 2026 | not given | Not stated |
| US | Everolimus, Tablet, 5 mg (NDC 0093-7767-24) discontinuation | Teva Pharmaceuticals USA, Inc. | 2 Mar 2026 | not given | Not stated |
| US | Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24) discontinuation | Teva Pharmaceuticals USA, Inc. | 2 Mar 2026 | not given | Not stated |
| US | Everolimus, Tablet, .25 mg (NDC 49884-158-02) discontinuation | Par Health, USA LLC | 14 Oct 2026 | not given | Not stated |
| US | Everolimus, Tablet, .5 mg (NDC 49884-159-02) discontinuation | Par Health, USA LLC | 14 Oct 2026 | not given | Not stated |
| US | Everolimus, Tablet, .75 mg (NDC 49884-160-02) discontinuation | Par Health, USA LLC | 14 Oct 2026 | not given | Not stated |
| US | Everolimus, Tablet, 1 mg (NDC 49884-283-02) discontinuation | Par Health, USA LLC | 14 Oct 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).